KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Arbutus Biopharma (ABUS) Interest Coverage Ratio: 2017-2025

Historic Interest Coverage Ratio for Arbutus Biopharma (ABUS) over the last 8 years, with Sep 2025 value amounting to -376.48.

  • Arbutus Biopharma's Interest Coverage Ratio rose 49.08% to -376.48 in Q3 2025 from the same period last year, while for Sep 2025 it was -429.39, marking a year-over-year increase of 22.01%. This contributed to the annual value of -557.07 for FY2024, which is 227.38% down from last year.
  • As of Q3 2025, Arbutus Biopharma's Interest Coverage Ratio stood at -376.48, which was down 808.43% from 53.14 recorded in Q2 2025.
  • Arbutus Biopharma's 5-year Interest Coverage Ratio high stood at 53.14 for Q2 2025, and its period low was -917.82 during Q1 2025.
  • Moreover, its 3-year median value for Interest Coverage Ratio was -464.43 (2024), whereas its average is -423.22.
  • In the last 5 years, Arbutus Biopharma's Interest Coverage Ratio slumped by 1,028.81% in 2023 and then spiked by 108.37% in 2025.
  • Arbutus Biopharma's Interest Coverage Ratio (Quarterly) stood at -37.14 in 2021, then slumped by 96.62% to -73.02 in 2022, then crashed by 545.78% to -471.52 in 2023, then climbed by 1.50% to -464.43 in 2024, then soared by 49.08% to -376.48 in 2025.
  • Its Interest Coverage Ratio stands at -376.48 for Q3 2025, versus 53.14 for Q2 2025 and -917.82 for Q1 2025.